NHC teamed up with BankProv, a future-ready commercial bank that offers adaptive and technology-first banking solutions to emerging markets and BDC Capital
Chamberlain's global headquarters. (Credit: Chamberlain Group/Wikipedia)
North Haven Capital (NHC), a private investment group based in Portland, Maine announced today that it has acquired New England-based Chamberlain Group (TCG). NHC teamed up with BankProv, a future-ready commercial bank that offers adaptive and technology-first banking solutions to emerging markets and BDC Capital, recognized locally and nationally as a leader and innovator in business lending and capital investment. Upstream Capital assisted in originating the transaction.
The Chamberlain Group is a leading designer, developer, and manufacturer of anatomical medical models, providing the best alternative to animals and cadavers for emerging medical device training and the associated procedures. NHC identified TCG as a scalable, high quality regional leader that has a global footprint and is ready to drive the expansion of its product offerings, target end markets, and international footprint.
Sam Sezak, Partner at North Haven Capital, said, “Lisa and Eric have built an extremely high-quality firm that takes great pride in its corporate culture and reputation with its client base. We’re excited to work with the employees of TCG to expand their presence geographically and into new products and service offerings.”
Lisa Chamberlain, founding co-partner of The Chamberlain Group said, “Eric and I are excited and pleased to work with North Haven Capital with the shared goals of providing a rewarding environment for our valued team members and increasing our market share both nationally and internationally. The team at North Haven brings energy and enthusiasm for growth and innovation that will serve our present and future clients in our mission of Bringing Practice to the Practice of Medicine.”
Source: Company Press Release